Malignant pleural mesothelioma: Current treatments and emerging drugs
2009-01-01 Belli, C.; Fennell, D.; Giovannini, M.; Gaudino, G.; Mutti, L.
In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells
2010-01-01 Melotti, A.; Daga, A.; Marubbi, D.; Zunino, A.; Mutti, L.; Corte, G.
Secondary and tertiary prevention of hereditary haemochromatosis in basic medicine
2008-01-01 Guala, A.; Lo Giudice, G.; Mutti, L.; Manfrinato, C.; Cadario, G.; De Vecchi, R.; Beltrametti, P.; Barberis, C.; Dupplicato, G.; Garampazzi, P.; Guido, A.; Maggio, G.; Miloni, G.; Moia, G.; Momo, C.; Rutigliano, M. A.; Sisca, C.; Stocchi, M.; Viola, V.
SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: A molecular epidemiologic case-control study
2005-01-01 Cristaudo, A.; Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P.; Tognon, M.; Mutti, L.; Puntoni, R.
Simian virus 40 and malignant mesothelioma (Review)
2003-01-01 Cerrano, P. G.; Jasani, B.; Filiberti, R.; Neri, M.; Merlo, F.; De Flora, S.; Mutti, L.; Puntoni, R.
Immunobiology and immune defence mechanisms of mesothelioma cells
1998-01-01 Mutti, L.
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients
2001-01-01 Castagneto, B.; Zai, S.; Mutti, L.; Lazzaro, A.; Ridolfi, R.; Piccolini, E.; Ardizzoni, A.; Fumagalli, L.; Valsuani, G.; Botta, M.
Variations in aspecific bronchial reactivity elicited by methacholine in chronic bronchitis patients treated with doxofylline. Double blind cross-over study versus theophylline slow-release
1991-01-01 Mutti, L.; Castagneto, B.; Occhionero, L.; Botta, M.; Degiovanni, D.; Budel, P.; Piccolini, E.; Dealessi, M.; Dini, F. L.
Preliminary data suggestive of a novel translational approach to mesothelioma treatment: Imatinib mesylate with gemcitabine or pemetrexed
2007-01-01 Bertino, P.; Porta, C.; Barbone, D.; Germano, S.; Busacca, S.; Pinato, S.; Tassi, G.; Favoni, R.; Gaudino, G.; Mutti, L.
The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor
2002-01-01 Cacciotti, P.; Strizzi, L.; Vianale, G.; Iaccheri, L.; Libener, R.; Porta, C.; Tognon, M.; Gaudino, G.; Mutti, L.
Advances in the systemic therapy of malignant pleural mesothelioma
2008-01-01 Fennell, D. A.; Gaudino, G.; O'Byrne, K. J.; Mutti, L.; van Meerbeeck, J.
Gamma/delta T-lymphocytes in advanced pulmonary asbestosis
1993-01-01 Mutti, L.; Piacenza, A.; Guaschino, R.; Castagneto, B.; Betta, P. G.
BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
2008-01-01 Fennell, D. A.; Chacko, A.; Mutti, L.
Establishment of four new mesothelioma cell lines: Characterization by ultrastructural and immunophenotypic analysis
1999-01-01 Orengo, A. M.; Spoletini, L.; Procopio, A.; Favoni, R. E.; De Cupis, A.; Ardizzoni, A.; Castagneto, B.; Ribotta, M.; Betta, P. G.; Ferrini, S.; Mutti, L.
Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts
2008-01-01 Bertino, P.; Piccardi, F.; Porta, C.; Favoni, R.; Cilli, M.; Mutti, L.; Gaudino, G.
Expression of glycoprotein 90K in human malignant pleural mesothelioma: Correlation with patient survival
2002-01-01 Strizzi, L.; Muraro, R.; Vianale, G.; Natoli, C.; Talone, L.; Catalano, A.; Mutti, L.; Tassi, G.; Procopio, A.
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma
2001-01-01 Cacciotti, P.; Libener, R.; Betta, P.; Martini, F.; Porta, C.; Procopio, A.; Strizzi, L.; Penengo, L.; Tognon, M.; Mutti, L.; Gaudino, G.
Translational therapies for malignant pleural mesothelioma
2010-01-01 Belli, C.; Anand, S.; Tassi, G.; Fennell, D.; Mutti, L.
Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma
2012-01-01 Pinton, G.; Manente, A. G.; Moro, L.; Mutti, L.
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
2008-01-01 Mutti, L.; Gaudino, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Malignant pleural mesothelioma: Current treatments and emerging drugs | 1-gen-2009 | Belli, C.; Fennell, D.; Giovannini, M.; Gaudino, G.; Mutti, L. | |
| In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells | 1-gen-2010 | Melotti, A.; Daga, A.; Marubbi, D.; Zunino, A.; Mutti, L.; Corte, G. | |
| Secondary and tertiary prevention of hereditary haemochromatosis in basic medicine | 1-gen-2008 | Guala, A.; Lo Giudice, G.; Mutti, L.; Manfrinato, C.; Cadario, G.; De Vecchi, R.; Beltrametti, P.; Barberis, C.; Dupplicato, G.; Garampazzi, P.; Guido, A.; Maggio, G.; Miloni, G.; Moia, G.; Momo, C.; Rutigliano, M. A.; Sisca, C.; Stocchi, M.; Viola, V. | |
| SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: A molecular epidemiologic case-control study | 1-gen-2005 | Cristaudo, A.; Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P.; Tognon, M.; Mutti, L.; Puntoni, R. | |
| Simian virus 40 and malignant mesothelioma (Review) | 1-gen-2003 | Cerrano, P. G.; Jasani, B.; Filiberti, R.; Neri, M.; Merlo, F.; De Flora, S.; Mutti, L.; Puntoni, R. | |
| Immunobiology and immune defence mechanisms of mesothelioma cells | 1-gen-1998 | Mutti, L. | |
| Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients | 1-gen-2001 | Castagneto, B.; Zai, S.; Mutti, L.; Lazzaro, A.; Ridolfi, R.; Piccolini, E.; Ardizzoni, A.; Fumagalli, L.; Valsuani, G.; Botta, M. | |
| Variations in aspecific bronchial reactivity elicited by methacholine in chronic bronchitis patients treated with doxofylline. Double blind cross-over study versus theophylline slow-release | 1-gen-1991 | Mutti, L.; Castagneto, B.; Occhionero, L.; Botta, M.; Degiovanni, D.; Budel, P.; Piccolini, E.; Dealessi, M.; Dini, F. L. | |
| Preliminary data suggestive of a novel translational approach to mesothelioma treatment: Imatinib mesylate with gemcitabine or pemetrexed | 1-gen-2007 | Bertino, P.; Porta, C.; Barbone, D.; Germano, S.; Busacca, S.; Pinato, S.; Tassi, G.; Favoni, R.; Gaudino, G.; Mutti, L. | |
| The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor | 1-gen-2002 | Cacciotti, P.; Strizzi, L.; Vianale, G.; Iaccheri, L.; Libener, R.; Porta, C.; Tognon, M.; Gaudino, G.; Mutti, L. | |
| Advances in the systemic therapy of malignant pleural mesothelioma | 1-gen-2008 | Fennell, D. A.; Gaudino, G.; O'Byrne, K. J.; Mutti, L.; van Meerbeeck, J. | |
| Gamma/delta T-lymphocytes in advanced pulmonary asbestosis | 1-gen-1993 | Mutti, L.; Piacenza, A.; Guaschino, R.; Castagneto, B.; Betta, P. G. | |
| BCL-2 family regulation by the 20S proteasome inhibitor bortezomib | 1-gen-2008 | Fennell, D. A.; Chacko, A.; Mutti, L. | |
| Establishment of four new mesothelioma cell lines: Characterization by ultrastructural and immunophenotypic analysis | 1-gen-1999 | Orengo, A. M.; Spoletini, L.; Procopio, A.; Favoni, R. E.; De Cupis, A.; Ardizzoni, A.; Castagneto, B.; Ribotta, M.; Betta, P. G.; Ferrini, S.; Mutti, L. | |
| Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts | 1-gen-2008 | Bertino, P.; Piccardi, F.; Porta, C.; Favoni, R.; Cilli, M.; Mutti, L.; Gaudino, G. | |
| Expression of glycoprotein 90K in human malignant pleural mesothelioma: Correlation with patient survival | 1-gen-2002 | Strizzi, L.; Muraro, R.; Vianale, G.; Natoli, C.; Talone, L.; Catalano, A.; Mutti, L.; Tassi, G.; Procopio, A. | |
| SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma | 1-gen-2001 | Cacciotti, P.; Libener, R.; Betta, P.; Martini, F.; Porta, C.; Procopio, A.; Strizzi, L.; Penengo, L.; Tognon, M.; Mutti, L.; Gaudino, G. | |
| Translational therapies for malignant pleural mesothelioma | 1-gen-2010 | Belli, C.; Anand, S.; Tassi, G.; Fennell, D.; Mutti, L. | |
| Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma | 1-gen-2012 | Pinton, G.; Manente, A. G.; Moro, L.; Mutti, L. | |
| The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma | 1-gen-2008 | Mutti, L.; Gaudino, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista38797
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa29
- 2020 - 202610567
- 2010 - 201912538
- 2000 - 20098046
- 1990 - 19995281
- 1980 - 19892072
- 1970 - 1979262
- 1966 - 19694
Editore
- EDP Sciences2
- Eliseo Ranzi, Katharina Kohse-Höi...2
- Humana Press Inc.2
- Wiley Online Library2
- Brill1
- Cambridge University Press: 20111
- Edizioni dell'U.M.I.1
- Elsevier1
- GIOVANNI COSTA1
- IFIP1
Rivista
- PHYSICAL REVIEW LETTERS179
- PLOS ONE150
- IEEE TRANSACTIONS ON ELECTROMAGNE...141
- L'INDUSTRIA DELLE COSTRUZIONI140
- APPLIED SCIENCES137
- PHYSICAL REVIEW. B, CONDENSED MAT...135
- INTERNATIONAL JOURNAL OF MOLECULA...131
- SCIENTIFIC REPORTS125
- TRANSPLANTATION PROCEEDINGS118
- ENERGIES106
Serie
- METHODS IN MOLECULAR BIOLOGY2
Keyword
- Humans1211
- Female618
- Male577
- Adult341
- Italy311
- Middle Aged300
- Aged247
- COVID-19240
- Neurology (clinical)227
- Child212
Lingua
- eng27811
- ita5263
- fre99
- spa97
- ger42
- lat9
- pol7
- por6
- rus6
- enm5
Accesso al fulltext
- no fulltext27069
- open8257
- restricted2454
- reserved922
- partially open90
- mixed4
- embargoed3